Postoperative urinary dysfunction following lateral lymph node dissection for rectal cancer via minimally invasive surgery
- PMID: 39716123
- PMCID: PMC11664852
- DOI: 10.1186/s12893-024-02697-5
Postoperative urinary dysfunction following lateral lymph node dissection for rectal cancer via minimally invasive surgery
Abstract
Background: Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction.
Methods: The subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC.
Results: Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC.
Conclusions: There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function.
Keywords: Duration of urinary catheterization; Laparoscopic surgery; Lateral lymph node resection; Rectal cancer; Removal of urinary catheter; Robot-assisted laparoscopic surgery; Urinary dysfunction.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Institutional Review Board of Juntendo University (approval number: H19-0214). Consent for publication: Due to the retrospective nature of this study, the requirement for informed consent was waived. Competing interests: The authors declare no competing interests.
Figures


Similar articles
-
Short- and long-term outcomes of robot-assisted versus laparoscopic lateral lymph node dissection for rectal cancer.Langenbecks Arch Surg. 2025 Jun 7;410(1):178. doi: 10.1007/s00423-025-03747-z. Langenbecks Arch Surg. 2025. PMID: 40481892 Free PMC article.
-
Postoperative morbidity and mortality after mesorectal excision with laparoscopic versus conventional open lateral lymph node dissection for advanced rectal cancer: A meta-analysis.Asian J Surg. 2021 Jan;44(1):26-35. doi: 10.1016/j.asjsur.2020.06.010. Epub 2020 Aug 11. Asian J Surg. 2021. PMID: 32798083
-
Short-term outcomes of laparoscopic lateral pelvic node dissection for advanced lower rectal cancer.Surg Endosc. 2021 Apr;35(4):1572-1578. doi: 10.1007/s00464-020-07534-3. Epub 2020 Apr 3. Surg Endosc. 2021. PMID: 32246236
-
The efficacy and safety of lateral lymph node dissection for patients with rectal cancer: A systematic review and meta-analysis.Asian J Surg. 2020 Sep;43(9):891-901. doi: 10.1016/j.asjsur.2019.11.006. Epub 2020 Jan 9. Asian J Surg. 2020. PMID: 31926817
-
Robotic-assisted versus laparoscopic-assisted extended mesorectal excision: a comprehensive meta-analysis and systematic review of perioperative and long-term outcomes.Surg Endosc. 2024 Nov;38(11):6464-6475. doi: 10.1007/s00464-024-11222-x. Epub 2024 Sep 13. Surg Endosc. 2024. PMID: 39269481
Cited by
-
ICG fluorescence-guided sentinel lymph node biopsy for decision-making in lateral lymph node dissection in local advanced rectal cancer: a retrospective study.Updates Surg. 2025 Apr 9. doi: 10.1007/s13304-025-02169-2. Online ahead of print. Updates Surg. 2025. PMID: 40205080
References
-
- Kinugasa T, Akagi Y, Ochi T, Ishibashi Y, Tanaka N, Oka Y, et al. Lateral lymph-node dissection for rectal cancer: meta-analysis of all 944 cases undergoing surgery during 1975–2004. Anticancer Res. 2013;33(7):2921–7. - PubMed
-
- Ishibe A, Ota M, Watanabe J, Suwa Y, Suzuki S, Kanazawa A, et al. Prediction of lateral pelvic lymph-node metastasis in low rectal cancer by magnetic resonance imaging. World J Surg. 2016;40(4):995–1001. - PubMed
-
- Inoue H, Sasaki K, Nozawa H, Kawai K, Murono K, Emoto S, et al. Therapeutic significance of D3 dissection for low rectal cancer: a comparison of dissections between the lateral pelvic lymph nodes and the lymph nodes along the root of the inferior mesenteric artery in a multicenter retrospective cohort study. Int J Colorectal Dis. 2021;36(6):1263–70. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical